Moreover, the prognostic analysis of the TCGA CRC cohort revealed that CRC patients with higher ANGPTL2, COLEC11, and SPP1 tend to undergo worse overall survival (Figure 3C). This evidence concerns the gene COLEC11 and colorectal carcinoma.